Moradi Amir, Weiner Steven F.
J Drugs Dermatol. 2019 Jan 1;18(1):59-64.
Background: The safety and effectiveness of high-intensity precision radiofrequency (RF) for rejuvenating the aging neck and face, and of fractional laser therapy for treating photodamaged skin have each been previously demonstrated. Objective: To assess the effects of combining high-intensity precision RF and fractional laser therapy for treating the aging face and neck. Methods and Materials: Subjects (N=19) with Fitzpatrick skin types I to VI and mild-to-moderate solar elastosis and sun or age-related pigmentation on the face and/or neck were sequentially treated with high-intensity precision RF and fractionated laser devices during the same session. Three sessions were completed 30 days apart. Assessments were made 90 days after the last treatment. Results: Both Clinician and Subject Global Assessment of Improvement scores indicated clinical improvement (n=16, 84%) or no change (n=3, 16%) in skin quality. Clinical improvement was also observed in 16 subjects (68%) in masked assessment. Most subjects (90%) noted improved skin quality and 74% expressed at least some satisfaction with their treatment results. The most common adverse events were erythema (n=57, 45%) and edema (n=45, 35%). Conclusion: The results of this study establish the safety and effectiveness of combined treatment with a 1927 nm thulium laser and a high-intensity precision RF device. ClinicalTrials.gov Identifier: NCT03409965. J Drugs Dermatol. 2019;18(1):59-64.
高强度精准射频用于面部和颈部抗衰的安全性和有效性,以及非剥脱性激光疗法用于治疗光损伤皮肤的安全性和有效性此前均已得到证实。目的:评估高强度精准射频联合非剥脱性激光疗法对面部和颈部老化的治疗效果。方法和材料:选取19例皮肤类型为Fitzpatrick I至VI型、面部和/或颈部有轻度至中度日光性弹力组织变性以及日晒或年龄相关色素沉着的受试者,在同一次治疗中依次使用高强度精准射频设备和非剥脱性激光设备进行治疗。每隔30天完成一次,共进行三次治疗。在最后一次治疗90天后进行评估。结果:临床医生和受试者的整体改善评估评分均显示皮肤质量有临床改善(n = 16,84%)或无变化(n = 3,16%)。在盲法评估中,16名受试者(68%)也观察到了临床改善。大多数受试者(90%)注意到皮肤质量有所改善,74%的受试者对治疗结果至少表示了一定程度的满意。最常见的不良事件是红斑(n = 57,45%)和水肿(n = 45,35%)。结论:本研究结果证实了1927nm铥激光与高强度精准射频设备联合治疗的安全性和有效性。ClinicalTrials.gov标识符:NCT03409965。《药物皮肤病学杂志》。2019;18(1):59 - 64。